SEC Comment Letter 0000000000-23-002096 to GENETHERA INC (CIK 0001017110)
GENETHERA INC (CIK 0001017110)
Date: March 2, 2023 · CIK: 0001017110 · Accession: 0000000000-23-002096
AI Filing Summary & Sentiment
File numbers found in text: 000-27237
Letter
United States securities and exchange commission logo March 2, 2023 Tanya Irizarry Chief Financial Officer GeneThera Inc. 3051 W. 105th Ave. #350251 Westminster, CO 80035 Re:GeneThera Inc. Form 10-K for the Fiscal Year Ended December 31, 2021 Filed April 14, 2022 File No. 000-27237 Dear Tanya Irizarry: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
March 2, 2023
Tanya Irizarry
Chief Financial Officer
GeneThera Inc.
3051 W. 105th Ave. #350251
Westminster, CO 80035
Re:GeneThera Inc.
Form 10-K for the Fiscal Year Ended December 31, 2021
Filed April 14, 2022
File No. 000-27237
Dear Tanya Irizarry:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences